FIELD: medicine, pharmacy. SUBSTANCE: invention relates to dry, solid oral composition for delivery of drug that is made as multiple of granules. Granules comprise polymeric matrix where from 15 to 70 wt.-% of fat, oily or glue substance are included in combination with pharmaceutically active substance or indicated amount of pharmaceutically active substance that shows fat, oily or glue properties. Polymeric matrix consists of polyethylene glycol or mixture of polyethylene glycols that are solid at environment temperature. Pharmaceutically active substance is peptide drug inhibiting thrombin, dihydropyridine drug or alendronate. Composition elicits properties of rapid release that provides simultaneous delivery of drug and absorption enhancer or solubility enhancer to required site in the high concentration. High gradient of concentration enhances possibility for drug absorption. EFFECT: improved and valuable properties of granules. 11 cl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
POROUS HYDROXYAPATITE PARTICLES AS DRUG CARRIERS | 1998 |
|
RU2219907C2 |
PROLONGED-RELEASE ORAL PHARMACEUTICAL MEDICINAL FORM | 1998 |
|
RU2214232C2 |
METHOD FOR PREPARING METOPROLOL-CONTAINING MICROPARTICLES | 2002 |
|
RU2292878C2 |
PHARMACEUTICAL COMPOSITION | 2002 |
|
RU2323006C2 |
IMMEDIATE-RELEASED TABLET | 1999 |
|
RU2252751C2 |
NOVEL FILM COATING | 2002 |
|
RU2323717C2 |
ORAL PHARMACEUTICAL MEDICINAL FORM WITH DISCRETE RELEASE | 1998 |
|
RU2205028C2 |
SEMIFIRM SYSTEMS CONTAINING DERIVATIVES OF AZETIDINUM | 2004 |
|
RU2343915C2 |
NEW SELF-EMULSIFIED DRUG DELIVERY SYSTEM | 2001 |
|
RU2275908C2 |
SOLID MEDICINAL FORM, CONTAINING PROTON PUMP INHIBITOR, AND SUSPENSION OBTAINED FROM IT | 2005 |
|
RU2397756C2 |
Authors
Dates
2003-11-20—Published
1998-11-18—Filed